PEN-866 in Patients With Advanced Solid Malignancies

NCT03221400 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma
Endometrial Adenocarcinoma
Neoplasms
Squamous Cell Carcinoma of the Anus
Adenocarcinoma of the Pancreas
Advanced Cancer
Solid Tumor
Solid Carcinoma
Squamous Cell Carcinoma of the Cervix
Squamous Cell Carcinoma
Squamous Cell Carcinoma of the Vulva
Squamous Cell Carcinoma of the Penis
Gastric Cancer
Gastric Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Small-cell Lung Cancer
Small Cell Lung Carcinoma
Pancreatic Ductal Adenocarcinoma
Pancreatic Adenocarcinoma

Interventions

DRUG: PEN-866 Sodium
DRUG: fluorouracil
DRUG: Folinic acid
DRUG: Niraparib

Sponsor

Tarveda Therapeutics